ImmunoCellular Therapeutics Ltd

Biotechnology ResearchCalifornia, United States2-10 Employees

ImmunoCellular Therapeutics, Ltd. is a biotechnology research company based in Los Angeles, California, focused on developing immune-based therapies for brain and other cancers. Its lead program, ICT-107, is a dendritic cell–based immunotherapy aimed at targeting multiple tumor-associated antigens on glioblastoma stem cells, with a phase 2 trial completed. The company’s pipeline also includes ICT-121 for recurrent glioblastoma and ICT-140 for ovarian cancer stem cells, alongside a Stem-to-T-cell program that engineers patient hematopoietic stem cells to generate cancer-killing T-cells. This positions ImmunoCellular within the clinical-stage segment of cancer immunotherapy, emphasizing personalized, antigen-directed approaches.

Operating in the biotechnology research industry, ImmunoCellular serves clinical development pathways and potential future patients by pursuing therapies that stimulate the immune system to recognize and attack cancerous cells. The organization is located in Calabasas, in the greater Los Angeles area, and has pursued multiple programs addressing brain cancers and other tumor types. Recent activity includes public disclosures about its ongoing work in immune-based cancer therapies.

Sign up for free to view info

Email Format Employee directory